Bugge, Nora Stensland
Vetvik, Kjersti Grøtta
Alstadhaug, Karl Bjørnar
Braaten, Tonje
Funding for this research was provided by:
UiT The Arctic University of Norway
Article History
Received: 12 February 2025
Accepted: 2 June 2025
First Online: 20 June 2025
Declarations
:
: All participants provided written informed consent. The study has been licensed by the Norwegian Data Inspectorate (2002/2241) and approved by the Regional Committee for Medical and Health Research Ethics (REC-635219).
: Not applicable.
: KGV has received honoraria for lecturing and/or participation in advisory boards from Novartis, TEVA, Roche, Pfizer, Lundbeck, Eli Lilly and Abbvie.